Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2018-05-10 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
更正本公司107年1-3月份營業收入及關係人銷貨金額
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (科妍生物科技股份有限公司) correcting previously reported monthly operating revenue and related party sales amounts for the first quarter of the year 107 (Taiwan calendar, equivalent to 2018). It provides corrected figures for January to March and explains the reason for the correction as compliance with IFRS 15. The document is brief (1196 characters) and does not contain full financial statements or detailed analysis. It is essentially a regulatory correction notice rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2018-05-10 Chinese
107年第1季海外子公司投資
Interim / Quarterly Report Classification · 90% confidence The document contains financial data related to investment in overseas subsidiaries, including investment amounts, holding percentages, and recognized investment gains or losses for a specific quarter (107年1季, which corresponds to Q1 of a fiscal year). The content is tabular and provides detailed financial figures rather than just an announcement or summary. The length is short (623 characters), but it contains substantive financial data for a quarterly period. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements or substantive financial data and analysis for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification, so it should not be classified as RPA or RNS. Therefore, the best fit is IR (Interim / Quarterly Report). Q1 2018
2018-05-10 Chinese
107年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, and investment income recognized. The document is relatively short (1279 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or announcement. It does not contain comprehensive financial statements or management discussion, nor is it an announcement of a meeting or voting results. The content aligns with a regulatory filing providing specific investment data as required by authorities, fitting best under the category of Regulatory Filings (RNS).
2018-05-10 Chinese
107年4月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a specific month and year (April 2018, 民國107年04月) provided by a listed company. It contains numerical data on net operating revenue, comparisons with the previous year, and explanations for revenue changes. The document is short (798 characters) and does not contain comprehensive financial statements or detailed analysis. It is a periodic revenue update rather than a full interim or annual report. It does not fit the definition of an Interim/Quarterly Report (IR) because it lacks substantive financial data and analysis. It is also not an Earnings Release (ER) since it is more of a revenue summary than a key highlights announcement. Given the nature and length, it is best classified as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not neatly fit into other categories.
2018-05-10 Chinese
107年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 科妍, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without any detailed financial statements, management discussion, or regulatory certifications. It does not contain any narrative or comprehensive financial report. It appears to be a regulatory disclosure or compliance update rather than a full report or announcement of a report. Given the short length and nature of the data, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-05-10 Chinese
107年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the year 107 (which corresponds to 2018 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2361 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2018
2018-05-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.